[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 312,902
  • Shares Outstanding, K 56,995
  • Annual Sales, $ 5,820 K
  • Annual Income, $ 71,180 K
  • EBIT $ -89 M
  • EBITDA $ -86 M
  • 60-Month Beta 1.35
  • Price/Sales 54.84
  • Price/Cash Flow N/A
  • Price/Book 2.20

Options Overview Details

View History
  • Implied Volatility 68.79% (-72.58%)
  • Historical Volatility 46.56%
  • IV Percentile 1%
  • IV Rank 1.00%
  • IV High 1,170.59% on 01/14/26
  • IV Low 57.72% on 08/19/25
  • Expected Move (DTE 30) 0.74 (13.77%)
  • Put/Call Vol Ratio 0.74
  • Today's Volume 381
  • Volume Avg (30-Day) 1,101
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 25,889
  • Open Int (30-Day) 29,282
  • Expected Range 4.63 to 6.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.22
  • Number of Estimates 4
  • High Estimate $-0.14
  • Low Estimate $-0.33
  • Prior Year $-0.58
  • Growth Rate Est. (year over year) +62.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.22 +2.78%
on 04/29/26
6.07 -11.53%
on 05/06/26
-0.13 (-2.36%)
since 04/17/26
3-Month
4.23 +26.95%
on 03/30/26
6.07 -11.53%
on 05/06/26
+0.25 (+4.88%)
since 02/18/26
52-Week
4.00 +34.25%
on 11/07/25
7.54 -28.78%
on 08/15/25
-0.73 (-11.97%)
since 05/16/25

Most Recent Stories

More News
Abeona Therapeutics Q1 Earnings Call Highlights

Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center activation...

ABEO : 5.37 (-2.19%)
Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 5.37 (-2.19%)
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update

- Three patients treated with ZEVASKYN ® in Q1 2026 - - QTC network expands to six sites, with two new additions on the East Coast -  - In-licensed radically novel engineered T-cell technology...

ABEO : 5.37 (-2.19%)
ABEO's Gene Therapy Revenue Model Gets Its First Real-World Readout Tomorrow

Barchart Research What to Expect from ABEO Earnings ABEO Generated May 12, 2026 Current Price $5.68 EPS Estimate $$-0.33 Consensus Rating Strong Buy Average Move 8.46% ABEO's Gene Therapy Revenue Model...

ABEO : 5.37 (-2.19%)
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®

CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need,...

ABEO : 5.37 (-2.19%)
Abeona Therapeutics® Announces Date of First Quarter Financial Results

CLEVELAND, May 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Wednesday, May 13, 2026 at 8:30 a.m. ET to discuss its financial...

ABEO : 5.37 (-2.19%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, May 01, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards...

ABEO : 5.37 (-2.19%)
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors

CLEVELAND, April 07, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Keith A. Goldan as a new independent member to its Board of Directors, effective...

ABEO : 5.37 (-2.19%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, April 06, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards...

ABEO : 5.37 (-2.19%)
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University Irving Medical Center in New York, NY as the...

ABEO : 5.37 (-2.19%)

Business Summary

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

See More

Key Turning Points

3rd Resistance Point 5.74
2nd Resistance Point 5.64
1st Resistance Point 5.50
Last Price 5.37
1st Support Level 5.26
2nd Support Level 5.16
3rd Support Level 5.02

See More

52-Week High 7.54
Fibonacci 61.8% 6.19
Fibonacci 50% 5.77
Last Price 5.37
Fibonacci 38.2% 5.35
52-Week Low 4.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.